Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices-Enhanced stability and release

Journal of Controlled Release

Volumn 156, Issue 3, 2011, Pages 390-397

  Valo, Hanna ^a   Kovalainen, Miia ^c   Laaksonen, Päivi ^b   Häkkinen, Merja ^c   Auriola, Seppo ^c   Peltonen, Leena ^a   Linder, Markus ^b   Järvinen, Kristiina ^c   Hirvonen, Jouni ^a   Laaksonen, Timo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Drug release; Fusion proteins; Hydrophobins; Nanofibrillar cellulose; Nanoparticles; Pharmaceutical nanotechnology

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; AQUEOUS SOLUBILITY; CELLULOSE BINDING DOMAINS; CELLULOSE MATRIX; CELLULOSE NANOFIBRILS; DISSOLUTION RATES; DRUG NANOPARTICLES; DRUG RELEASE; FORMULATION PROCESS; FUNCTIONALIZED; FUSION PROTEINS; HYDROPHOBINS; IN-VIVO; ITRACONAZOLE; MATRIX; NANO-DISPERSIONS; NANOFIBRILLAR; NANOFIBRILLAR MATRIX; NANOMETER-SIZED PARTICLES; NANOSIZING; STORAGE STABILITY;

CELLULOSE; GENETIC ENGINEERING; MORPHOLOGY; NANOTECHNOLOGY; PROTEINS;

NANOPARTICLES;

CELLULOSE; HYDROPHOBIN; ITRACONAZOLE; NANOFIBRILLAR CELLULOSE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; IN VIVO STUDY; MALE; MORPHOLOGY; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIFUNGAL AGENTS; BINDING SITES; CELLULOSE; DRUG CARRIERS; FREEZE DRYING; FUNGAL PROTEINS; FUNGI; IMMOBILIZED PROTEINS; ITRACONAZOLE; MALE; NANOPARTICLES; PARTICLE SIZE; PROTEIN BINDING; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 82755197868     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.016     Document Type: Article

References (37)

1. A.T. Florence Pharmaceutical nanotechnology: more than size: ten topics for research Int. J. Pharm. 339 2007 1 2 (Pubitemid 46977614)
2. B. Bhushan, and Y.C. Jung Natural and biomimetic artificial surfaces for superhydrophobicity, self-cleaning, low adhesion, and drag reduction Prog. Mater. Sci. 56 2011 1 108
3. L.A. Lee, and Q. Wang Adaptations of nanoscale viruses and other protein cages for medical applications Nanomedicine 2 2006 137 149 (Pubitemid 44403221)
4. K. Scholtmeijer, M.I. Janssen, B. Gerssen, M.L. de Vocht, B.M. van Leeuwen, T.G. van Kooten, H.A.B. Woesten, and J.G. Wessels Surface modifications created by using engineered hydrophobins Appl. Environ. Microbiol. 68 2002 1367 1373 (Pubitemid 34205378)
5. H.A.B. Wösten Hydrophobins: multipurpose proteins Annu. Rev. Microbiol. 55 2001 625 646 (Pubitemid 32978118)
6. M.B. Linder Hydrophobins: proteins that self assemble at interfaces Curr. Opin. Colloid Interface Sci. 14 2009 356 363
7. J.G.H. Wessels Developmental regulation of fungal cell wall formation Annu. Rev. Phytopathol. 32 1994 413 437 (Pubitemid 2151443)
8. H.K. Valo, P.H. Laaksonen, L.J. Peltonen, M.B. Linder, J.T. Hirvonen, and T.J. Laaksonen Multifunctional hydrophobin: toward functional coatings for drug nanoparticles ACS Nano 4 2010 1750 1758
9. M.B. Linder, and T.T. Teeri The roles and function of cellulose-binding domains J. Biotechnol. 57 1997 15 28 (Pubitemid 27397467)
10. M. Linder, I. Salovuori, L. Ruohonen, and T.T. Teeri Characterization of a double cellulose-binding domain J. Biol. Chem. 271 1996 21268 21272
11. S. Varjonen, P. Laaksonen, A. Paananen, H. Valo, H. Hahl, T. Laaksonen, and M.B. Linder Self-assembly of cellulose nanofibrils by genetically engineered fusion proteins Soft Matter 7 2011 2402 2411
12. M. Pääkkö, M. Ankerfors, H. Kosonen, A. Nykänen, S. Ahola, M. Österberg, J. Ruokolainen, J. Laine, P.T. Larsson, O. Ikkala, and T. Lindström Enzymatic hydrolysis combined with mechanical shearing and high-pressure homogenization for nanoscale cellulose fibrils and strong gels Biomacromolecules 8 2007 1934 1941 (Pubitemid 47009973)
13. R.T. Olsson, M.A.S. Azizi Samir, G. Salazar-Alvarez, L. Belova, V. Strom, L.A. Berglund, O. Ikkala, J. Nogues, and U.W. Gedde Making flexible magnetic aerogels and stiff magnetic nanopaper using cellulose nanofibrils as templates Nat. Nanotechnol. 5 2010 584 588
14. M. Pääkkö, J. Vapaavuori, R. Silvennoinen, H. Kosonen, M. Ankerfors, T. Lindström, A.L. Berglund, and O. Ikkala Long and entangled native cellulose I nanofibers allow flexible aerogels and hierarchically porous templates for functionalities Soft Matter 4 2008 2492 2499
15. M. Henriksson, L.A. Berglund, P. Isaksson, T. Lindström, and T. Nishino Cellulose nanopaper structures of high toughness Biomacromolecules 9 2008 1579 1585 (Pubitemid 351954431)
16. M. Linder, K. Selber, T. Nakari-Setälä, M. Qiao, M. Kula, and M. Penttilä The hydrophobins HFBI and HFBII from Trichoderma reesei showing efficient interactions with nonionic surfactants in aqueous two-phase systems Biomacromolecules 2 2001 511 517 (Pubitemid 32707532)
17. M.B. Linder, M. Qiao, F. Laumen, K. Selber, T. Hyytiä, T. Nakari-Setälä, and M.A. Penttilä Efficient purification of recombinant proteins using hydrophobins as tags in surfactant-based two-phase systems Biochemistry 43 2004 11873 11882 (Pubitemid 39277634)
18. L.A. Decosterd, B. Rochat, B. Pesse, T. Mercier, F. Tissot, N. Widmer, J. Bille, T. Calandra, B. Zanolari, and O. Marchetti A multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, boriconazole-N-oxide, anidulafungin, and caspofungin Antimicrob. Agents Chemother. 54 2010 5303 5315
19. FDA Guidance for industry, bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) available(4.4.2011) http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf
20. Z. Wang, J. Chen, Y. Le, Z. Shen, and J. Yun Preparation of ultrafine beclomethasone dipropionate drug powder by antisolvent precipitation Ind. Eng. Chem. Res. 46 2007 4839 4845 (Pubitemid 47116475)
21. M.E. Matteucci, M.A. Hotze, K.P. Johnston, and R.O. Williams Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization Langmuir 22 2006 8951 8959 (Pubitemid 44626160)
22. A. Zimmermann, A. Millqvist-Fureby, M.R. Elema, T. Hansen, A. Müllertz, and L. Hovgaard Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties Eur. J. Pharm. Biopharm. 71 2009 109 116
23. D. Xia, P. Quan, H. Piao, H. Piao, S. Sun, Y. Yin, and F. Cui Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability Eur. J. Pharm. Sci. 40 2010 325 334
24. C. Eyholzer, N. Bordeanu, F. Lopez-Suevos, D. Rentsch, T. Zimmermann, and K. Oksman Preparation and characterization of water-redispersible nanofibrillated cellulose in powder form Cellulose 17 2010 19 30
25. D.J. Gardner, G.S. Oporto, R. Mills, and M.A.S.A. Samir Adhesion and surface issues in cellulose and nanocellulose J. Adhes. Sci. Tech. 22 2008 545 567
26. Z. Wang, M. Lienemann, M. Qiau, and M.B. Linder Mechanisms of protein adhesion on surface films of hydrophobin Langmuir 26 2010 8491 8496
27. J. Kerc, and S. Srcic Thermal analysis of glassy pharmaceuticals Thermochim. Acta 248 1995 81 95
28. B.C. Hancock, and G. Zografi Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
29. F. Sussich, and A. Cesàro Trehalose amorphization and recrystallization Carbohydr. Res. 343 2008 2667 2674
30. S.E. Pagnotta, S.E. McLain, A.K. Soper, F. Bruni, and M.A. Ricci Water and trehalose: how much do they interact with each other? J. Phys. Chem. B 114 2010 4904 4908
31. J.F. Carpenter, and J.H. Crowe An infrared spectroscopic study of the interactions of carbohydrates with dried proteins Biochemistry 28 1989 3916 3922 (Pubitemid 19125443)
32. K. Six, G. Verreck, J. Peeters, K. Binnemans, H. Berghmans, P. Augustijns, R. Kinget, and G. Van den Mooter Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase Thermochim. Acta. 376 2001 175 181 (Pubitemid 32803453)
33. M. Van Speybroeck, R. Mols, R. Mellaerts, T.D. Thi, J.A. Martens, J.V. Humbeeck, P. Annaert, G. Van den Mooter, and P. Augustijns Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole Eur. J. Pharm. Biopharm. 75 2010 354 365
34. T. Loftsson, P. Jarho, M. Masson, and T. Jaervinen Cyclodextrins in drug delivery Expert Opin. Drug Deliv. 2 2005 335 351 (Pubitemid 41130887)
35. V.J. Stella, and R.A. Rajewski Cyclodextrins: their future in drug formulation and delivery Pharm. Res. 14 1997 556 567 (Pubitemid 27220271)
36. K.O. Uekama, and M. Otagiri Cyclodextrins in drug carrier systems Crit. Rev. Ther. Drug Carr. Syst. 3 1987 1 40 (Pubitemid 17231927)
37. J. Peeters, P. Neeskens, J.P. Tollenaere, P. Van Remoortere, and M.E. Brewster Characterization of the interaction of 2-hydroxypropyl-beta- cyclodextrin with itraconazole at pH 2, 4, and 7 J. Pharm. Sci. 91 2002 1414 1422